🇺🇸 FDA
Patent

US 6472179

Receptor based antagonists and methods of making and using

expired A61PA61P19/10A61P35/00

Quick answer

US patent 6472179 (Receptor based antagonists and methods of making and using) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P19/10, A61P35/00